Monotherapy With Levetiracetam in Newly Diagnosed Patients Suffering From Epilepsy

Inclusion Criteria: * Subjects with newly or recently diagnosed epilepsy having experienced unprovoked partial seizures (IA, IB, IC with clear focal origin), or generalized tonic-clonic seizures (without clear focal origin), that are classifiable according to the International Classification of Epileptic Seizures. The discrimination between IC and IIE is not requested for inclusion. * Subjects with at least 2 unprovoked seizures separated by a minimum of 48 hours in the year preceding randomization out of which at least 1 unprovoked seizure in the 3 months preceding randomization. * Subjects with a confirmed diagnosis of epilepsy. * Male/female subjects (≥16 years). Exclusion Criteria: * History or presence of seizures of other types than partial (IA, IB, IC, with clear focal origin) and generalized tonic-clonic (without clear focal origin) seizures. * History or presence of seizures occurring only in clustered patterns, defined as repeated seizures occurring over a short period of time, i.e. \< 20 minutes, with or without function regained between 2 ictal events. * History, clinical or EEG finding suggestive of idiopathic generalized epilepsy (IGE) at randomization.